Skip to main content
    N

    Nu Skin Enterprises Inc (NUS)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $3.94
    -0.09 (-2.11%)

    Market Cap: $196.17M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nu Skin Enterprises Inc (NUS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Nu Skin Enterprises reported revenue of $1.49B for the fiscal year ended Dec 31, 2025, down 14.3% from the year before. That year, net income was $160.20M with a net margin of 10.8%, operating cash flow was $80.29M and free cash flow was $46.01M. The quarter ended Sep 30, 2026 had revenue of $311.01M and net income of -$742.00K.

    Revenue and Margins

    The operating margin was 4.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $2.21B, a compound annual decline of 4.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.49B-14.3%69.4%4.4%10.8%
    Dec 2024$1.73B-12.0%68.2%-8.8%-8.5%
    Dec 2023$1.97B-11.5%68.9%2.5%0.4%
    Dec 2022$2.23B-17.4%71.7%5.0%4.7%
    Dec 2021$2.70B+4.4%75.0%8.7%5.5%
    Dec 2020$2.58B+6.7%74.5%10.0%7.4%
    Dec 2019$2.42B-9.7%76.0%11.0%7.2%
    Dec 2018$2.68B+17.5%76.3%9.0%4.5%
    Dec 2017$2.28B+3.2%78.0%12.0%5.7%
    Dec 2016$2.21BN/A77.3%10.5%6.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.49B$1.73B$1.97B$2.23B$2.70B$2.58B$2.42B$2.68B$2.28B$2.21B
    Cost of revenue$453.76M$550.23M$611.85M$630.91M$675.22M$658.03M$581.42M$634.14M$502.08M$500.46M
    Gross profit$1.03B$1.18B$1.36B$1.59B$2.02B$1.92B$1.84B$2.04B$1.78B$1.71B
    Operating income$65.76M-$151.59M$48.27M$110.85M$233.99M$257.56M$267.43M$240.86M$274.48M$231.10M
    Net income$160.20M-$146.59M$8.60M$104.78M$147.27M$191.35M$173.55M$121.89M$129.44M$143.09M
    EBITDA$262.41M-$78.83M$123.06M$174.97M$308.78M$330.22M$331.82M$302.67M$337.13M$285.24M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$311.01M$320.11M$320.61M$370.32M$364.21M$386.14M$364.49M$445.55M$430.14M$439.08M$417.31M$488.64M
    Gross profit$202.17M$218.32M$214.46M$261.98M$256.72M$265.73M$246.96M$279.15M$301.46M$307.18M$294.06M$352.43M
    Operating income$5.09M-$59.32M$4.03M$23.24M$21.64M$30.78M-$9.90M-$53.08M$18.23M-$125.56M$8.82M$16.06M
    Net income-$742.00K-$249.80M$1.84M$14.49M$17.08M$21.12M$107.52M-$36.10M$8.30M-$118.26M-$533.00K$7.28M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $224.19M by $14.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.41B$1.47B$1.81B$1.82B$1.91B$1.96B$1.77B$1.69B$1.59B$1.47B
    Current assets$547.70M$538.60M$701.87M$759.87M$872.95M$903.20M$740.17M$799.24M$777.79M$714.34M
    Cash and equivalents$238.63M$186.88M$256.06M$264.73M$339.59M$402.68M$335.63M$386.91M$426.40M$357.25M
    Total liabilities$600.07M$817.46M$986.66M$923.67M$993.71M$1.06B$893.72M$912.58M$885.28M$809.98M
    Short-term debt$20.00M$30.00M$25.00M$25.00M$107.50M$30.00M$27.50M$69.45M$77.84M$82.73M
    Long-term debt$204.19M$363.61M$478.04M$377.47M$268.78M$305.39M$334.46M$361.01M$310.79M$334.17M
    Shareholder equity$805.24M$651.46M$821.97M$897.30M$912.77M$894.27M$875.29M$781.87M$704.60M$664.07M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.09B$1.12B$1.38B$1.41B$1.42B$1.44B$1.39B$1.47B$1.58B$1.59B$1.74B$1.81B
    Total liabilities$540.60M$578.79M$582.71M$600.07M$624.61M$655.94M$637.44M$817.46M$876.02M$899.81M$931.71M$986.66M
    Cash and equivalents$164.90M$189.64M$198.65M$238.63M$251.79M$264.16M$203.77M$186.88M$227.75M$224.25M$212.53M$256.06M
    Shareholder equity$547.48M$542.74M$794.09M$805.24M$799.79M$787.75M$753.97M$651.46M$706.88M$686.16M$810.21M$821.97M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 57.3% of operating cash flow. Dividends and share repurchases together came to 69.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$80.29M$111.74M$118.64M$108.06M$141.58M$379.14M$177.93M$202.74M$302.56M$275.26M
    Capital expenditures$34.28M$41.58M$58.49M$59.06M$68.61M$63.82M$66.07M$70.37M$60.16M$50.22M
    Free cash flow$46.01M$70.16M$60.15M$49.01M$72.97M$315.32M$111.86M$132.37M$242.40M$225.04M
    Dividends paid$11.83M$11.93M$77.62M$77.02M$76.27M$78.39M$82.19M$80.58M$76.06M$78.44M
    Share repurchases$20.04M$0$13.01M$70.05M$80.42M$144.33M$825.00K$69.56M$71.73M$247.21M
    Investing cash flow$170.66M-$37.96M-$134.50M-$67.08M-$88.73M-$79.43M-$71.41M-$108.76M-$91.96M-$57.86M
    Financing cash flow-$202.40M-$133.18M$10.73M-$99.50M-$104.70M-$245.17M-$154.79M-$116.71M-$159.57M-$134.71M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$8.12M$10.63M-$3.92M$16.62M$27.48M$35.80M$389.00K$25.79M$31.43M$51.21M$3.32M$54.17M
    Capital expenditures$11.35M$5.64M$13.71M$10.76M$9.91M$18.00K$13.58M$12.58M$8.60M$8.12M$12.28M$20.39M
    Free cash flow-$19.47M$4.99M-$17.63M$5.86M$17.57M$35.78M-$13.20M$13.20M$22.84M$43.08M-$8.96M$33.78M
    Last 12 quarters

    Frequently Asked Questions About NUS

    What is Nu Skin Enterprises' annual revenue?

    Nu Skin Enterprises reported revenue of $1.49B for the fiscal year ended Dec 31, 2025.

    How fast is Nu Skin Enterprises' revenue growing?

    Revenue was down 14.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -12.6%.

    Is Nu Skin Enterprises profitable?

    Yes. Nu Skin Enterprises reported net income of $160.20M for the fiscal year ended Dec 31, 2025, with a net margin of 10.8%.

    How much free cash flow does NUS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $80.29M minus capital expenditures of $34.28M produced free cash flow of $46.01M.

    How much debt does Nu Skin Enterprises have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $204.19M, short-term debt of $20.00M and cash and equivalents of $238.63M.